Vaccines against bacterial meningitis.
نویسندگان
چکیده
Meningitis remains an important cause of morbidity and mortality among children >5 years of age and is especially prevalent in developing countries. Effective routine immunization against Hib, pneumococcus and serogroupC meningococcus has had a significant impact on both invasive disease and carriage caused by these encapsulated bacteria. The major challenge in prevention of meningitis remains the delivery of vaccines worldwide, especially to resource-poor regions with the greatest disease burden.
منابع مشابه
Identification of the serotypes of bacterial meningitis agents; implication for vaccine usage
BACKGROUND AND OBJECTIVES Bacterial meningitis is one of the most serious infections and should be treated as emergency. As it has significant morbidity and mortality throughout the world, every country should have precise information regarding the etiological agents of disease and populations at risk to design public health prevention strategy. In the present study in addition of evaluation of...
متن کاملImmunological Aspect of Meningococcal disease: An overview in Host- Bacteria Interaction
Meningococcal disease remains a significant global public health and is unique among causes of bacterial meningitis and sepsis where it not only causes sporadic disease but also outbreaks. Meningococcal disease has a rapid onset with high mortality. The understanding of immunopathogenesis is crucial for development of novel therapeutic strategies and vaccines designed against meningococcal dise...
متن کاملTechnical Development of a New Meningococcal Conjugate Vaccine
BACKGROUND Group A Neisseria meningitidis has been a major cause of bacterial meningitis in the sub-Saharan region of Africa in the meningitis belt. Neisseria meningitidis is an encapsulated pathogen, and antibodies against the capsular polysaccharide are protective. Polysaccharide-protein conjugate vaccines have proven to be highly effective against several different encapsulated bacterial pat...
متن کامل1 Meningococcal Vaccines : Current Status and 2 Emerging Strategies 3
Neisseria meningitidis causes most cases of bacterial meningitis. Meningococcal meningitis 8 is a public health burden to both developed and developing countries throughout the world. There 9 are a number of vaccines (polysaccharide-based, glycoconjugate, protein-based and combined 10 conjugate vaccines) that are approved to target five of the six disease-causing serogroups of the 11 pathogen. ...
متن کاملBacterial meningitis in Finland, 1995–2014: a population-based observational study
OBJECTIVES Bacterial meningitis remains an important cause of morbidity and mortality worldwide. Its epidemiological characteristics, however, are changing due to new vaccines and secular trends. Conjugate vaccines against Haemophilus influenzae type b and Streptococcus pneumoniae (10-valent) were introduced in 1986 and 2010 in Finland. We assessed the disease burden and long-term trends of fiv...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- British medical bulletin
دوره 72 شماره
صفحات -
تاریخ انتشار 2004